Participated · Series A · Feb 2024

MediConCen provides an automated, AI- and blockchain-based insurance claims platform using Hyperledger technology and a cashless claim network. The company holds blockchain patents in the US and Hong Kong and is led by CEO William Yeung. Its platform serves more than 16 insurers, over 1 million insured individuals, and includes 1,200 medical providers. MediConCen plans to use the new funds to accelerate international growth, specifically targeting the Middle East and Southeast Asia. The company is a Cyberport community start-up and joined the Cyberport Incubation Programme in 2018. The article also notes the company had received USD 12.7M (unspecified) in prior funding.

Participated · Equity · May 2022

MotionsCloud is a German insurtech that uses augmented reality and artificial intelligence to assess and expedite home and auto insurance claims. Led by CEO LeX Tan, the company provides an automated property and vehicle inspection solution designed to make claims processing faster and more efficient. Its platform leverages AR and AI to automate inspections and support insurers in damage assessment and claims workflows. MotionsCloud already cooperates with firms across Europe, the US and Asia. The company raised US$2m in a funding round and intends to use the proceeds to pursue further expansion efforts. Investors in the round included SOSV, Net Insurance, AI Startup Incubator, ParticleX, Artesian, Excon Services and Global Insurance Accelerator.

Participated · Equity · Nov 2021

Model Medicines is an AI/ML drug discovery company that leverages a historical compendium of drug development data and a drug- and disease-agnostic discovery platform to create Phase II/III-ready drug candidates. The company has developed a pipeline of patent-pending therapeutics across oncology, infectious diseases, gastric disorders, neurological disorders, and weight disorders. It recently used its platform to discover MDL-001, a once-daily oral infectious disease candidate moved from concept to IND-enabling studies in less than 12 months and at a fraction of traditional development costs. Model Medicines also identified and validated over 30 in vitro disease-model drug candidates for novel infectious disease targets discovered by Sanford Burnham Prebys and virologist Dr. Sumit Chanda. Following the $4.1M financing, the company plans to bolster its internal therapeutic pipeline, expand R&D to broaden platform functionality and enhance discovery efficacy, and recruit scientific, clinical, technical, and business leaders. The company is led by CEO Daniel Haders II, Ph.D., and is based in San Diego, CA.

Led · Seed · Sep 2021

Homeppl combines anti-fraud technology with Open Banking data to screen tenants, protect landlords from fraud, and reduce discrimination in access to housing. The company says it protected clients from potential losses of more than £3 million during 2021. Homeppl has a team of more than 30 professionals and plans to double its headcount within the next year. The recent funding round raised $1.4 million at a $13.5 million post-money valuation, bringing total seed capital to over $5 million. The proceeds are expected to fund the next phase of growth as the business moves toward a Series A and to support expansion into several European cities. Investors and supporters cited belief in the proposition and the team’s ability to scale. Homeppl is a London-based tenant referencing platform founded by Alexander Siedes. It assesses tenants' real risk level, enabling letting agents to fast-track growth while reducing fraud, default, and delays. The system leverages Open Banking along with proprietary behavioral analysis and fraud detection tests to evaluate tenants' financial situations and ability to afford rent. Homeppl serves large letting firms including Knight Frank and the Countrywide Group and has approved more than £1bn of revenue to its clients. The company is a Barclays Techstars participant. It plans to use new funds to expand further in the UK rental market and to add staff in R&D, operations, and sales.

Participated · Seed · Mar 2021

viAct offers an AI-powered impact monitoring platform that provides real-time risk detection, predictive analytics and automated interventions for industrial projects. The platform serves over 200 contractors globally and supports sectors including construction, oil and gas, and logistics. viAct says its solution helps prevent incidents while improving project timelines, operational efficiency and profitability. The company is led by CEO Gary Ng and COO Hugo Cheuk. viAct plans to use new funding to advance its AI capabilities, expand globally and grow its team. viAct offers an AI-based cloud platform that combines computer vision, edge devices and a mobile app to provide around-the-clock monitoring of construction sites. Its platform detects potential safety hazards, construction progress, and the location of machinery and materials, and sends real-time alerts to a mobile app designed for on-site engineers. The company serves more than 30 construction industry clients across Asia and Europe. viAct was founded in 2016 and is headquartered in Hong Kong. The startup plans to use new funding to support research and development, product development, and geographic expansion into Southeast Asian markets including Indonesia, Vietnam and Singapore.